Diseases, Conditions, Syndromes

Evaluating an old molecule to fight SARS-CoV-2

In the spring of 2020, Université de Montréal biochemistry professor Christian Baron had an idea: Why not evaluate the inhibition capacity of a commercially available molecule called VE607 on the virus causing COVID-19?

Neuroscience

Young veterans with mild TBI show premature cognitive aging

(HealthDay)—Subtle, subclinical cognitive problems observed in specific cognitive domains in young veterans with mild traumatic brain injury (mTBI) are similar to those seen in patients with early-stage Parkinson disease ...

Medical research

Formula milk trials are not reliable, warn experts

Formula milk trials have a high risk of bias, authors almost always report favorable conclusions, transparency is lacking, and findings are selectively reported, finds a review of evidence from recently published trials in ...

Overweight & Obesity

Dieting: Villain or scapegoat?

For decades, there has been an accepted definition of dieting in academia, and in society as a whole. Michael Lowe, Ph.D., a professor in Drexel University's College of Arts and Sciences, has recently reevaluated the decades ...

Ophthalmology

Vision impairment tied to cognitive decline

(HealthDay)—Worse visual acuity, contrast sensitivity, and stereo acuity impairment are associated with an increased risk for cognitive decline in older, community-dwelling individuals, according to a study published online ...

page 4 from 11